0001041024FALSE00010410242024-05-212024-05-21

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):  May 21, 2024
 
ROCKWELL MEDICAL, INC.
(Exact name of registrant as specified in its charter)
 
Delaware000-2366138-3317208
(State or other jurisdiction
of incorporation)		(Commission File Number)(IRS Employer
Identification No.)
 
30142 S. Wixom Road, Wixom, Michigan 48393
(Address of principal executive offices, including zip code)
 
(248) 960-9009
(Registrant’s telephone number, including area code)
 
N/A
(Former name or former address, if changed since last report)
  
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of Each Class Trading Symbol Name of Each exchange on which registered
Common Stock, par value $0.0001 RMTI 
Nasdaq Capital Market
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company ☐


 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 




Item 5.07        Submission of Matters to a Vote of Security Holders.

On May 21, 2024, Rockwell Medical, Inc. held its 2024 Annual Meeting of the Stockholders (the "Annual Meeting"). The following matters were submitted to a vote of the stockholders at the Annual Meeting and the voting results were as follows:
Proposal One: To elect the two Class III directors to serve for a three-year term expiring at the 2027 annual meeting of stockholders and until his successor has been duly elected and qualified.

ForAgainstAbstainBroker Non-Votes
Robert S. Radie11,524,139 160,366 48,056 8,117,274 
Mark Strobeck, Ph.D.11,517,800 164,730 50,031 8,117,274 

Proposal Two: To approve, on an advisory basis, the compensation of the Company's named executive officers.
ForAgainstAbstainBroker Non-Votes
11,126,598 522,245 83,718 8,117,274 

Proposal Three: To ratify the selection of EisnerAmper LLP as the Company’s independent registered public accounting firm for 2024.
ForAgainstAbstain
19,446,483 210,240 193,112 





SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 ROCKWELL MEDICAL, INC.
   
Date: May 23, 2024By: /s/ Mark Strobeck
  Mark Strobeck
  Chief Executive Officer

v3.24.1.1.u2
Cover
May 21, 2024
Cover [Abstract]  
Document Type 8-K
Entity Registrant Name ROCKWELL MEDICAL, INC.
Entity Incorporation, State or Country Code DE
Entity File Number 000-23661
Entity Tax Identification Number 38-3317208
Entity Address, City or Town Wixom
Entity Address, State or Province MI
Entity Address, Postal Zip Code 48393
City Area Code 248
Local Phone Number 960-9009
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.0001
Trading Symbol RMTI
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0001041024
Amendment Flag false
Document Period End Date May 21, 2024
Entity Address, Address Line One 30142 S. Wixom Road
Grafico Azioni Rockwell Medical (NASDAQ:RMTI)
Storico
Da Nov 2024 a Dic 2024 Clicca qui per i Grafici di Rockwell Medical
Grafico Azioni Rockwell Medical (NASDAQ:RMTI)
Storico
Da Dic 2023 a Dic 2024 Clicca qui per i Grafici di Rockwell Medical